Citigroup
HAE icon

Citigroup’s Haemonetics HAE Stock Holding History

Citigroup’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.2M Sell
251,922
-317,251
-56% -$20.7M 0.01% 1261
2025
Q4 		$45.6M Buy
569,173
+140,132
+33% +$9.42M 0.02% 673
2025
Q3 		$20.9M Sell
429,041
-6,576
-2% -$407K 0.01% 1038
2025
Q2 		$32.5M Sell
435,617
-189,948
-30% -$12.6M 0.02% 736
2025
Q1 		$39.8M Buy
625,565
+291,574
+87% +$19.8M 0.02% 648
2024
Q4 		$26.1M Buy
333,991
+140,333
+72% +$11.3M 0.02% 816
2024
Q3 		$15.6M Sell
193,658
-36,717
-16% -$2.97M 0.01% 1087
2024
Q2 		$19.1M Buy
230,375
+152,935
+197% +$13.5M 0.01% 912
2024
Q1 		$6.61M Sell
77,440
-72,759
-48% -$5.71M ﹤0.01% 1524
2023
Q4 		$12.8M Sell
150,199
-1,029
-0.7% -$89K 0.01% 1090
2023
Q3 		$13.5M Sell
151,228
-27,390
-15% -$2.45M 0.01% 960
2023
Q2 		$15.2M Buy
178,618
+74,190
+71% +$6.27M 0.01% 943
2023
Q1 		$8.64M Sell
104,428
-41,268
-28% -$3.34M 0.01% 1225
2022
Q4 		$11.5M Buy
145,696
+48,101
+49% +$3.87M 0.01% 1061
2022
Q3 		$7.23M Sell
97,595
-36,131
-27% -$2.59M 0.01% 1327
2022
Q2 		$8.72M Buy
133,726
+14,624
+12% +$865K 0.01% 1224
2022
Q1 		$7.53M Buy
119,102
+7,271
+7% +$395K ﹤0.01% 1444
2021
Q4 		$5.93M Sell
111,831
-2,039
-2% -$124K ﹤0.01% 1699
2021
Q3 		$8.04M Buy
113,870
+3,656
+3% +$231K ﹤0.01% 1530
2021
Q2 		$7.34M Buy
110,214
+55,076
+100% +$3.9M ﹤0.01% 1629
2021
Q1 		$6.12M Buy
55,138
+43,299
+366% +$5.36M ﹤0.01% 1658
2020
Q4 		$1.41M Buy
11,839
+1,130
+11% +$122K ﹤0.01% 3208
2020
Q3 		$934K Sell
10,709
-15,548
-59% -$1.36M ﹤0.01% 3329
2020
Q2 		$2.35M Sell
26,257
-2,239
-8% -$226K ﹤0.01% 2634
2020
Q1 		$2.84M Buy
28,496
+4,355
+18% +$472K ﹤0.01% 2157
2019
Q4 		$2.77M Buy
24,141
+20,122
+501% +$2.43M ﹤0.01% 2637
2019
Q3 		$507K Sell
4,019
-122
-3% -$15.5K ﹤0.01% 4330
2019
Q2 		$498K Sell
4,141
-25,684
-86% -$2.53M ﹤0.01% 4434
2019
Q1 		$2.61M Buy
29,825
+4,827
+19% +$439K ﹤0.01% 2394
2018
Q4 		$2.5M Buy
24,998
+21,346
+585% +$2.24M ﹤0.01% 2454
2018
Q3 		$419K Buy
3,652
+1,581
+76% +$164K ﹤0.01% 4495
2018
Q2 		$186K Sell
2,071
-14,572
-88% -$1.23M ﹤0.01% 5139
2018
Q1 		$1.22M Sell
16,643
-15,230
-48% -$1.04M ﹤0.01% 3070
2017
Q4 		$1.85M Sell
31,873
-14,151
-31% -$745K ﹤0.01% 2750
2017
Q3 		$2.06M Sell
46,024
-9,347
-17% -$388K ﹤0.01% 2623
2017
Q2 		$2.19M Buy
55,371
+2,242
+4% +$92.1K ﹤0.01% 2497
2017
Q1 		$2.15M Sell
53,129
-45,752
-46% -$1.79M ﹤0.01% 2407
2016
Q4 		$3.98M Buy
98,881
+61,546
+165% +$2.32M ﹤0.01% 2100
2016
Q3 		$1.35M Buy
37,335
+13,001
+53% +$446K ﹤0.01% 2899
2016
Q2 		$706K Sell
24,334
-14,381
-37% -$435K ﹤0.01% 3289
2016
Q1 		$1.35M Buy
38,715
+36,010
+1,331% +$1.16M ﹤0.01% 2971
2015
Q4 		$86K Sell
2,705
-905
-25% -$29.4K ﹤0.01% 5493
2015
Q3 		$116K Sell
3,610
-324
-8% -$12.2K ﹤0.01% 4871
2015
Q2 		$163K Sell
3,934
-1,075
-21% -$45.3K ﹤0.01% 4595
2015
Q1 		$225K Buy
5,009
+1,761
+54% +$73.6K ﹤0.01% 4428
2014
Q4 		$121K Sell
3,248
-1,816
-36% -$66.5K ﹤0.01% 5094
2014
Q3 		$177K Buy
5,064
+328
+7% +$11.7K ﹤0.01% 4319
2014
Q2 		$167K Buy
4,736
+1,882
+66% +$62.9K ﹤0.01% 4280
2014
Q1 		$93K Sell
2,854
-17,388
-86% -$665K ﹤0.01% 5057
2013
Q4 		$852K Sell
20,242
-8,288
-29% -$341K ﹤0.01% 3335
2013
Q3 		$1.14M Sell
28,530
-3,288
-10% -$138K ﹤0.01% 2808
2013
Q2 		$1.32M Buy
+31,818
New +$1.29M ﹤0.01% 2680

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citigroup's HAE Position: Q1 2026 in Review

Citigroup reduced its Haemonetics (HAE) stake by 56% in Q1 2026, selling an estimated $20.7M and leaving 251,922 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #1261.

Citigroup first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.6M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Citigroup held 251,922 shares of Haemonetics worth $14.2M as of Q1 2026.
  • Citigroup sold 317,251 Haemonetics shares in Q1 2026, an estimated $20.7M.
  • Haemonetics made up 0.01% of Citigroup's portfolio in Q1 2026, its #1261 holding.
  • Citigroup first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Haemonetics position peaked at $45.6M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.